Nevertheless, in agreement with its overexpression and negative correlation with survival in human basal-like breast cancer patients, loss of GRHL2 in basal A cells leads to reduced growth of orthotopic tumors and lung colonies, indicating that growth suppression is the dominant response to GRHL2 loss. The gene discussed is GRHL2; the disease is breast carcinoma.